Article
Hematologic aspects of liver transplantation for Budd-Chiari syndrome with special reference to myeloproliferative disorders.
Transplantation - 27 Oct 2002
Melear Jason M, Goldstein Robert M, Levy Marlon F, Molmenti Ernesto P, Cooper Barry, Netto George J, Klintmalm Goran B, Stone Marvin J
Abstract excerpt
BACKGROUND: Patients who undergo orthotopic liver transplantation (OLT) for Budd-Chiari syndrome (BCS) traditionally have been anticoagulated with warfarin postoperatively. Because a significant proportion of BCS patients are found to have an underlying myeloproliferative disorder (MPD), antiplat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
